Investor FAQ
Smith & Nephew is a leading global advanced medical devices company with operations in 33 countries. Our business is structured in four divisions:Orthopaedic Reconstruction , Orthopaedic Trauma and Clinical Therapies , Endoscopy, and Advanced Wound Management. They focus on repairing and healing the human body by developing innovative products whose performance has earned the trust of clinicians throughout the world. We are proud that every day our products help improve people's lives. We have one set of Values worldwide: Performance - Innovation - Trust. By sharing the same business principles worldwide, we aim to achieve our ambitions while recognising and fulfilling our responsibilities to all those involved with our business.
We want to be known as a company that:
Smith & Nephew is a leading global advanced medical devices company with operations in 33 countries. Our business is structured in four divisions:Orthopaedic Reconstruction , Orthopaedic Trauma and Clinical Therapies , Endoscopy, and Advanced Wound Management. They focus on repairing and healing the human body by developing innovative products whose performance has earned the trust of clinicians throughout the world. We are proud that every day our products help improve people's lives. We have one set of Values worldwide: Performance - Innovation - Trust. By sharing the same business principles worldwide, we aim to achieve our ambitions while recognising and fulfilling our responsibilities to all those involved with our business.
We want to be known as a company that:
Smith & Nephew has operations in 33 countries. Its main markets are the Americas, Europe and the UK.
In 2006 Smith & Nephew had over 8,800 employees.
Smith & Nephew has a focused strategy that has rewarded our shareholders and laid the foundation for continued success. We are No1 in the world in Arthroscopy (minimally invasive surgery of the joint) business segments. We are a leader in the Advanced Wound Management market with a reputation for innovation and strength of product range. Our Orthopaedic Reconstruction business is No. 4 in the global market and has a reputation for being one of the most innovative. The Trauma and Clinical Therapies business is No. 2 in the world with leading ranges of internal and external fixation systems as well as offering low frequency ultrasound bone healing and joint fluid therapy products.
Smith & Nephew has a focused strategy that has rewarded our shareholders and laid the foundation for continued success. We are No1 in the world in Arthroscopy (minimally invasive surgery of the joint) business segments. We are a leader in the Advanced Wound Management market with a reputation for innovation and strength of product range. Our Orthopaedic Reconstruction business is No. 4 in the global market and has a reputation for being one of the most innovative. The Trauma and Clinical Therapies business is No. 2 in the world with leading ranges of internal and external fixation systems as well as offering low frequency ultrasound bone healing and joint fluid therapy products.